These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effect of head hypothermia on serum inflammatory cytokines levels in patients with hypertensive intracerebral hemorrhage].
    Author: Zhang XM, Li XL, Tang SH, Liu QC.
    Journal: Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2006 May; 18(5):294-6. PubMed ID: 16700996.
    Abstract:
    OBJECTIVE: To study changes in interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) levels in hypertensive intracerebral hemorrhage (HIH) and observe the potential effect of head hypothermia. METHODS: One hundred and twenty four cases of HIH were divided into head hypothermia treatment group (n=63) and control group (n=61) according to treatment with or without head hypothermia. The serum IL-6 and TNF-alpha level in the two groups were determined on the 2nd and 8th days with enzyme linked immunoadsorbent assay (ELISA) and radioimmunoassay, and compared to those of the healthy volunteers (n=40). In addition, the life quality scores of the two groups were compared. RESULTS: The serum IL-6 and TNF-alpha levels in both head hypothermia treatment group and control group were higher on the 2nd day after hospitalization compared with the healthy controls (all P<0.01), and there was no significant difference in serum IL-6 and TNF-alpha levels on the 2nd day between the head hypothermia treatment group and control group (both >0.05). Serum IL-6 and TNF-alpha levels in the head hypothermia treatment group on the 8th day after hyperthermia were significantly lower than those on the 2nd day after hospitalization (both P<0.05), while the changes of control group was not significant (both >0.05), and significant difference in serum IL-6 and TNF-alpha was found between head hypothermia treatment group and control group on day 8 (both P<0.01). The prognosis quality of life in head hypothermia treatment group was markedly higher than the control group (P<0.05). CONCLUSION: The levels of serum IL-6 and TNF-alpha were increased significantly during early stage of HIH. Head hypothermia can effectively reduce the serum IL-6 and TNF-alpha levels of early HIH patients, and improve the prognosis quality of life as well.
    [Abstract] [Full Text] [Related] [New Search]